Last Updated: Thursday, 9 April 2020, 6:37PM (NZDT)
If you are not experiencing COVID-19 symptoms, you can continue to use Continuous Positive Airway Pressure (CPAP) as normal. CPAP use in the home is unlikely to affect individuals who do not have COVID-19 nor should it increase the risk to family contacts in the home as long as the CPAP user is not symptomatic and contagious.
A CPAP machine is a therapy device for treating sleep apnea. CPAP use doesn’t prevent you from contracting COVID-19. Please refer to your national healthcare authority or your medical professional for more information about COVID-19 and contamination prevention.
If you have COVID-19 or are experiencing COVID-19 symptoms, it is important to talk to your healthcare professional before stopping CPAP therapy. CPAP use may slightly increase the risk of aerosolization of the virus which could increase the spreading of the virus to others. We therefore recommend that precautions are taken.
Precautions for family members should be as per the general recommendations of the World Health Organisation (WHO) and the Centers of Disease Control (CDC).
See CDC advice, Get Your Household Ready for Coronavirus Disease 2019
Follow the cleaning instructions in your Use and Care Guide. However, please note that cleaning any device or mask according to instructions in the Use and Care Guides is not equivalent to disinfection or sterilization. Disinfection processes have been provided to your CPAP therapy provider.
If you do not have your Use and Care Guide, please refer to the relevant product page on our website.
For CPAP Masks
For multi-patient reprocessing of Fisher & Paykel Healthcare CPAP masks, please follow the instructions in our mask Disinfection and Sterilization guides. These are available on each of the relevant product pages on our website, or you can ask your local sales representative. These instructions have been validated to achieve high-level disinfection* or sterilization* of our masks.
The virus that causes COVID-19 is from the coronavirus family of enveloped viruses1. These viruses are known to have a low resistance to microbicidal processes2. Therefore, the recommended disinfection and sterilization methods are sufficient according to the relevant required processes, e.g. Cidex OPA™ or Sterrad™. For more information on Disinfection and Sterilization, see https://www.cdc.gov/infectioncontrol/pdf/guidelines/disinfection-guidelines-H.pdf.
For CPAP Devices
For multi-patient reprocessing of Fisher & Paykel Healthcare CPAP devices, components that are exposed to the air path should only be cleaned or disinfected according to the F&P Disinfection and Sterilization guides. These are available on each of the relevant product pages on our website, or you can ask your local sales representative.
If the Disinfection and Sterilization Guides across our product range cannot be followed, then single-patient use is recommended.
There has been some concern among healthcare professionals about certain respiratory medical devices enabling the spread of COVID-19. CPAP therapy is not specifically named as an aerosol-generating procedure in the WHO Interim guidance for Infection prevention and control during health care when novel coronavirus infection is suspected3. However, there has been uncertainty about the potential creation of aerosols from all forms of non-invasive respiratory support.
The WHO interim guidelines for Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected4 state that recent publications suggest CPAP does not create widespread dispersion of exhaled air. However, there is uncertainty about whether CPAP use could potentially increase the risk of aerosolization of the virus. We recommend that individuals take precautions outlined in the WHO guidelines.
*High-level disinfection is defined as complete elimination of all microorganisms in or on an instrument, except for all bacterial spores if large numbers are present.
*Sterilization is the complete elimination of all viable microorganisms
Cidex is a registered trademark of Advanced Sterilization Products, a division of Ethicon Inc., a Johnson & Johnson Company. Sterrad is a registered trademark of Advanced Sterilization Products, a division of Ethicon Inc., a Johnson & Johnson Company.
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
The AIRVO 2 family enables the transition of Optiflow therapy across critical, non-critical areas of the hospital and into the home.
Humidification for patients using a mask at home
Humidification for patients with a tracheostomy at home
A flow range of 2 to 60 L/min allows for use across the care continuum - from the most acute hospital environment to the home
With Optiflow you can independently titrate flow and FiO2 according to your patient's needs
Introducing F&P Evora™ Full, our new compact full face CPAP mask. Evora Full is minimal contact with full performance featuring our next generation of Dynamic Support Technology™
The adaptable, reliable and robust humidification system. Use with Evaqua™ 2 circuit technology to minimize condensate
Updates and support for healthcare professionals
Join our global team. View and apply for jobs with us.
Get in touch with our team, find a distributor or send an enquire.
We value your privacy. Our websites and applications use cookies to function properly and securely.